Search research articles
Contact Us
Filters
Showing results (81-90 of 156) with videos related to
Page
of 16
Sort By:
American Journal of Clinical Oncology
|
February 1, 1994
Recombinant interferon alpha-2b in the treatment of diffuse malignant pleural mesothelioma
A Ardizzoni, M C Pennucci, B Castagneto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group
A Ardizzoni, H Hansen, P Dombernowsky, et al.
Gene Therapy
|
February 12, 1998
IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer
C Traversari, R Meazza, M Coppolecchia, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
British Journal of Cancer
|
September 1, 1996
Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer
R Meazza, S Marciano, S Sforzini, et al.
Oncology
|
January 1, 1988
Intrapleural natural beta interferon in the treatment of malignant pleural effusions
R Rosso, R Rimoldi, F Salvati, et al.
American Journal of Clinical Oncology
|
April 1, 1991
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP)
A Ardizzoni, R Rosso, F Salvati, et al.
The Laryngoscope
|
May 1, 1990
Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck
M Merlano, R Rosso, M R Sertoli, et al.
Cancer
|
July 1, 1990
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force
R Rosso, F Salvati, A Ardizzoni, et al.
Anticancer Research
|
May 1, 1993
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients
V Fusco, A Ardizzoni, F Merlo, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 156) with videos related to
Sort By:
Page
of 16
American Journal of Clinical Oncology
|
February 1, 1994
Recombinant interferon alpha-2b in the treatment of diffuse malignant pleural mesothelioma
A Ardizzoni, M C Pennucci, B Castagneto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group
A Ardizzoni, H Hansen, P Dombernowsky, et al.
Gene Therapy
|
February 12, 1998
IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer
C Traversari, R Meazza, M Coppolecchia, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
British Journal of Cancer
|
September 1, 1996
Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer
R Meazza, S Marciano, S Sforzini, et al.
Oncology
|
January 1, 1988
Intrapleural natural beta interferon in the treatment of malignant pleural effusions
R Rosso, R Rimoldi, F Salvati, et al.
American Journal of Clinical Oncology
|
April 1, 1991
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP)
A Ardizzoni, R Rosso, F Salvati, et al.
The Laryngoscope
|
May 1, 1990
Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck
M Merlano, R Rosso, M R Sertoli, et al.
Cancer
|
July 1, 1990
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force
R Rosso, F Salvati, A Ardizzoni, et al.
Anticancer Research
|
May 1, 1993
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients
V Fusco, A Ardizzoni, F Merlo, et al.
Page
of 16